Research Paper Volume 11, Issue 23 pp 10883—10901

Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer

class="figure-viewer-img"

Figure 1. Comparison of CD204, CD163, and CD206 mRNA expressions between tumors and normal tissues (A) comparison of CD204 mRNA expression between different subtypes (B) of all cases of breast cancer between stage I-II and III-IV (C), and in each subtype, including luminal A (D), luminal B (E), HER2-positive (F), and basal-like (G) cancers.